Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention-Reference-Cited by-同舟云学术

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention

Published:2012-09-04 Issue:10 Volume:126 Page:1185-1193
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Lamberts Morten¹,Olesen Jonas Bjerring¹,Ruwald Martin Huth¹,Hansen Carolina Malta¹,Karasoy Deniz¹,Kristensen Søren Lund¹,Køber Lars¹,Torp-Pedersen Christian¹,Gislason Gunnar Hilmar¹,Hansen Morten Lock¹

Affiliation:

1. From the Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup (M.L., J.B.O., M.H.R., C.M.H., D.K., S.L.K., C.T.-P., G.H.G., M.L.H.); and Department of Cardiology, the Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark (L.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

2. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting

3. Meta-Analysis of Trials Comparing Oral Anticoagulation and Aspirin versus Dual Antiplatelet Therapy after Coronary Stenting

4. Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

5. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

Cited by 378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention;Interventional Cardiology Clinics;2024-10

2. High Bleeding Risk in Patients Undergoing Coronary and Structural Heart Interventions;Interventional Cardiology Clinics;2024-10

3. Heparin-like effect of a dual antiplatelet and anticoagulant (APAC) agent on red blood cell deformability and aggregation in an experimental model;Journal of Thrombosis and Thrombolysis;2024-09-04

4. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications;Theranostics;2024

5. Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study;Journal of Pharmaceutical Health Care and Sciences;2023-12-12